Atyr Pharma Inc (NASDAQ: ATYR) on Monday, plunged -9.69% from the previous trading day, before settling in for the closing price of $0.75. Within the past 52 weeks, ATYR’s price has moved between $0.68 and $7.29.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.28%. The company achieved an average annual earnings per share of 5.58%. With a float of $95.25 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Atyr Pharma Inc is 2.80%, while institutional ownership is 64.86%. The most recent insider transaction that took place on Oct 08 ’25, was worth 612,437. In this transaction Director of this company bought 682,001 shares at a rate of $0.90, taking the stock ownership to the 1,095,024 shares. Before that another transaction happened on Oct 09 ’25, when Company’s Director bought 317,999 for $0.94, making the entire transaction worth $299,364. This insider now owns 1,413,023 shares in total.
Atyr Pharma Inc (ATYR) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.18 earnings per share (EPS) for the period topping the consensus outlook (set at -0.23) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.78% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Atyr Pharma Inc (ATYR) is currently performing well based on its current performance indicators. A quick ratio of 5.93 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 350.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Looking closely at Atyr Pharma Inc (NASDAQ: ATYR), its last 5-days average volume was 4.38 million, which is a drop from its year-to-date volume of 4.93 million. As of the previous 9 days, the stock’s Stochastic %D was 15.39%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 0.06%, which indicates a significant decrease from 1.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0611 in the past 14 days, which was lower than the 0.2914 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2661, while its 200-day Moving Average is $3.5495. However, in the short run, Atyr Pharma Inc’s stock first resistance to watch stands at $0.7414. Second resistance stands at $0.8026. The third major resistance level sits at $0.8353. If the price goes on to break the first support level at $0.6475, it is likely to go to the next support level at $0.6148. Now, if the price goes above the second support level, the third support stands at $0.5536.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
Market capitalization of the company is 66.65 million based on 97,987K outstanding shares. Right now, sales total 240 K and income totals -64,020 K. The company made 190 K in profit during its latest quarter, and -25,740 K in sales during its previous quarter.
